GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?

Eli Lilly said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking Wegovy and Zepbound injections in a late-stage trial ...

Zepbound (tirzepatide) is a brand-name injection doctors prescribe for weight loss, weight management, and more. It may take several months of using Zepbound before you see the drug’s full effects for ...

The Food and Drug Administration has approved the second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day and will compete with the pill ...

FDA approvals of Novo Nordisk's oral Wegovy and Eli Lilly's Foundayo have introduced needle-free obesity treatments, offering ...

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

AboutZepbound®(tirzepatide) injection Zepbound ® (tirzepatide) is the first and only dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist ...